ACTIVITY RECRUITMENT PLATFORM
    2.
    发明公开

    公开(公告)号:US20240020718A1

    公开(公告)日:2024-01-18

    申请号:US18352102

    申请日:2023-07-13

    CPC classification number: G06Q30/0214 G16H40/20

    Abstract: A system including a processor and computer readable medium (CRM) is described. The CRM stores instructions causing the processor to: display a user interface to enable a campaign activity (CA) on a user system. The CA is associated with a campaign and has a campaign activity property, and the user interface includes input fields corresponding to recruit information associated with a particular recruit; receive a user ID, the recruit information, and an activity indicator identifying the CA; schedule the CA identified by the activity indicator with the recruit information; receive a recruit identifier identifying the particular recruit and a recruit status indicative of whether the recruit completed the campaign activity; and allocate, to the user of the user system, a donation or a monetary value based upon the campaign activity property when the recruit status indicates the particular recruit successfully completed the CA.

    Fundraising platform
    3.
    发明授权

    公开(公告)号:US11763351B2

    公开(公告)日:2023-09-19

    申请号:US15472448

    申请日:2017-03-29

    CPC classification number: G06Q30/0279 G06Q30/0218

    Abstract: A non-transitory computer readable medium storing a set of computer executable instructions for running on a processor that cause the processor to: receive a video link to a video from a third party system. The video has an advertisement with one or more actions. At least one question related to the one or more actions of the advertisement and at least one correct answer to the question and at least one incorrect answer to the question is stored. The question is displayed on a donor system and the donor system is directed to the video via the video link. Then, at least one correct answer and at least one incorrect answer are displayed on the donor system.

    METHOD OF PREPARING FIBRONECTIN CONCENTRATES

    公开(公告)号:US20230235021A1

    公开(公告)日:2023-07-27

    申请号:US18098257

    申请日:2023-01-18

    CPC classification number: C07K14/745 C07K1/30 C07K1/34

    Abstract: Fibronectin enhances growth of adherent cells in culture. Methods herein involve producing human-derived fibronectin concentrate from the cryo-precipitation of plasma. Fibronectin concentrates from many donors are be pooled, filtered, and irradiated, followed by adjustment of the fibronectin concentration to fit individual customer needs. Aliquots of the final fibronectin Concentrate product can be used in cell therapy and regenerative medicine cell cultures.

    METHOD OF TREATING PLASMA FOR USE
    10.
    发明申请

    公开(公告)号:US20210215724A1

    公开(公告)日:2021-07-15

    申请号:US17143699

    申请日:2021-01-07

    Inventor: Charles Mooney

    Abstract: A method treats human plasma obtained from any donor and renders the plasma, or serum derived therefrom, compatible with any recipient regardless of the recipient's blood group. Broadly, the method mixes type-AB red blood cells with blood plasma containing antibodies which are anti-A antibodies, anti-B antibodies or both so as to form a blood-plasma mixture, which can be separated to obtain a refined plasma which is lower in antibodies than the initial blood plasma.

Patent Agency Ranking